Navigation Links
ANA598 Data Presented at AASLD Highlight Positive Clinical Profile of DAA Entering Phase IIb
Date:10/30/2010

2, 2010, Anadys will present additional data from the Phase II combination study showing that the addition of ANA598 to SOC conferred benefit independent of a patient's IL-28B genotype. In patients with the IL-28B genotype most responsive to SOC (referred to as CC), ANA598 accelerated the rate of achieving undetectable levels of virus, with 82% of patients who received ANA598 plus SOC achieving undetectable levels by week 4, compared to 27% of patients who received placebo plus SOC.  In patients with IL-28B genotypes less responsive to SOC (referred to as CT and TT, or collectively non-CC), ANA598 both accelerated the rate of achieving undetectable levels of virus and increased the percentage of patients with undetectable levels of virus at week 12.  In the non-CC patients, 38% of patients who received ANA598 plus SOC achieved undetectable levels of virus by week 4, compared to 8% of patients who received placebo plus SOC, and 73% of patients who received ANA598 plus SOC achieved undetectable levels of virus at week 12, compared to 47% of patients who received placebo plus SOC.  

Phase II Combination Study

In the ongoing Phase II study, approximately 90 treatment-naive genotype 1 HCV patients have received ANA598 or placebo in combination with Pegasys® (peginterferon alfa-2a) and Copegus® (ribavirin, USP) for 12 weeks at dose levels of 200 mg twice-daily (bid) or 400 mg bid, each with a loading dose of 800 mg bid on day one. After week 12, patients are to continue receiving SOC. Patients who achieved undetectable levels of virus at weeks 4 and 12 were randomized to stop all treatment at week 24 or 48. The primary endpoint of the study is the proportion of patients who achieve undetectable levels of virus at week 12 (defined as complete Early Virological Response, or cEVR). Additional endpoints include safety and tolerability as well as the proportion of patients with undetectable levels of v
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
2. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
3. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
4. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
5. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
6. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
7. ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients
8. ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients
9. Anadys Pharmaceuticals Commences Dosing in Phase II Study of ANA598
10. ANA598 Demonstrates Positive 4-Week Results at 200 mg BID
11. ANA598 Demonstrates SVR12 in 100% of First Group of HCV Patients Randomized to Stop All Treatment at Week 24
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)...  The board of directors of VirtualScopics, Inc. (NASDAQ: ... trial imaging solutions, today announced that James Groff ... immediately.  Mr. Groff has held the role of acting ... in January 2006 as an accounting manager and was ... the board of VirtualScopics asked Jim to assume the ...
(Date:8/21/2014)... 21, 2014  SI-BONE, Inc. ( San Jose, ... the use of the iFuse Implant System, ® ... of the sacroiliac (SI) joint, announced that Priority Health ... its Lumbar Fusion Medical Policy No. 91590-R4 providing positive ... policy states that the fusion procedure, which employs the ...
(Date:8/20/2014)...  The National Association of Drug Diversion Investigators ... the real-time, pseudoephedrine (PSE) blocking system in Kentucky. The ... (NPLEx), automatically blocks unlawful PSE sales and helps ... make arrests. Data released by NPLEx shows electronic ... the sale of more than 23,478 boxes of medicine ...
Breaking Medicine Technology:VirtualScopics, Inc. Names James Groff Chief Financial Officer 2VirtualScopics, Inc. Names James Groff Chief Financial Officer 3VirtualScopics, Inc. Names James Groff Chief Financial Officer 4SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 2SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 3Kentucky's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
(Date:8/21/2014)... Recently, Skmen.com, a distinguished garment supplier, has updated its ... casual dresses . From today until August 31, all clients ... when they are shopping at the company’s online store. ... to the newest quality standards; they are guaranteed to be ... worldwide ladies can also access the other cheap items in ...
(Date:8/21/2014)... August 21, 2014 AVEC Health ... announce the addition of Kerry Gillespie as Chief ... healthcare management experience, Gillespie brings an extremely robust ... executive management positions with prominent industry leading organizations ... as President of Triad Isotopes, Inc. a private ...
(Date:8/21/2014)... Top10BestSEOHosting.com has recently compared many professional web ... ) is one of the best cheap web ... of Top10BestSEOHosting.com states, “It is hard to find ... have outperformed their competitors on hosting features, uptime, ... the best web hosting at affordable prices.” ...
(Date:8/21/2014)... Georgia (PRWEB) August 21, 2014 Living ... and the atmosphere that comes along with it. A ... makes sure that such amenities are available. ... community in Fayetteville, Georgia and Community Association Management, LLC ... from American Parks Company to provide an additional amenity ...
(Date:8/21/2014)... the coronary arteries of chronic kidney disease patients may ... to a new study in the Journal of ... Researchers at the Johns Hopkins Bloomberg School of Public ... used measures of subclinical atherosclerosis in predicting the risk ... Approximately 50 percent of all patients with chronic kidney ...
Breaking Medicine News(10 mins):Health News:Charming Girls’ Casual Dresses Now Released by Distinguished Garment Company Skmen.com 2Health News:Kerry Gillespie Appointed as Chief Executive Officer of AVEC Health Solutions 2Health News:iPage Reviews Unveiled Online At Top10BestSEOHosting.com 2Health News:Recreation is the Heart of the Community at Simpson Mill Plantation; Chooses American Parks Company™ for New Playground Equipment 2Health News:Recreation is the Heart of the Community at Simpson Mill Plantation; Chooses American Parks Company™ for New Playground Equipment 3Health News:Measuring calcium buildup to predict heart disease in those with chronic kidney disease 2
... ... cardiac death (SCD) is the leading cause of natural death in the ... results in death within six minutes in the absence of appropriate medical attention. ... survive. Contrary to common perception, SCD is not the same as a ...
... new report issued by Milliman reveals the unrealized potential of height ... demonstrates that the commonly used metric for height and weight, the ... future healthcare costs. , , "BMI ... height and weight, and it is often used to categorize relative ...
... , , , , ... (Nasdaq: LNET ), the leading provider of media and ... the CL King Best Ideas Conference at the Omni Hotel ... Scott C. Petersen will discuss the Company,s overall strategy and its ...
... TORONTO, Sept. 15 /PRNewswire/ - Scientists from the Samuel ... have discovered a molecular link between intelligence and curiosity, ... improve learning. , In a paper, published in Neuron, ... Bechara Saab, Ph.D candidate at the Lunenfeld, studied the ...
... Breast cancer is one of the most,common cancers among ... IV breast cancer at the time of diagnosis**. Lack ... breast cancer is so,prevalent among this group. This October, ... importance of early detection and,diagnosis among the Hispanic community through ...
... , , CALABASAS HILLS, Calif., ... and technology consulting firm, is the recipient of The ALS ... support and involvement in the fight against Lou Gehrig,s Disease. ... corporate partner for supporting and advancing the mission and vision ...
Cached Medicine News:Health News:Filmmaker John Hughes' Recent Untimely Death is a Call for Better Understanding ,of Sudden Cardiac Death, the Leading Cause of Natural Death in the U.S. 2Health News:Filmmaker John Hughes' Recent Untimely Death is a Call for Better Understanding ,of Sudden Cardiac Death, the Leading Cause of Natural Death in the U.S. 3Health News:Filmmaker John Hughes' Recent Untimely Death is a Call for Better Understanding ,of Sudden Cardiac Death, the Leading Cause of Natural Death in the U.S. 4Health News:Filmmaker John Hughes' Recent Untimely Death is a Call for Better Understanding ,of Sudden Cardiac Death, the Leading Cause of Natural Death in the U.S. 5Health News:Filmmaker John Hughes' Recent Untimely Death is a Call for Better Understanding ,of Sudden Cardiac Death, the Leading Cause of Natural Death in the U.S. 6Health News:Milliman Report Addresses the Potential Impact of Height and Weight on Medical Costs 2Health News:LodgeNet Interactive to Present at the CL King Best Ideas Conference 2Health News:LodgeNet Interactive to Present at the CL King Best Ideas Conference 3Health News:LodgeNet Interactive to Present at the CL King Best Ideas Conference 4Health News:LodgeNet Interactive to Present at the CL King Best Ideas Conference 5Health News:Canadian researchers discover the first-ever link between intelligence and curiosity 2Health News:Adamari Lopez & Yoplait(R) Committed to Continue Raising Awareness for Breast Cancer Risk Reduction Among the Hispanic Community 2Health News:Adamari Lopez & Yoplait(R) Committed to Continue Raising Awareness for Breast Cancer Risk Reduction Among the Hispanic Community 3Health News:The ALS Association Honors Booz Allen Hamilton With the Inaugural Partnership for Success Award 2Health News:The ALS Association Honors Booz Allen Hamilton With the Inaugural Partnership for Success Award 3Health News:The ALS Association Honors Booz Allen Hamilton With the Inaugural Partnership for Success Award 4
... This kit, comprised of Salicylic Acid ... 35%, is to be used by ... It is designed for intense skin ... enhance the speed of skin correction. ...
Catalyst for skin rejuvenation. Rapidly exfoliates superficial skin problems....
... homegeneous polymethylmethacrylate (PMMA) microspheres, evenly suspended in ... All microspheres are in a range of ... and have polymerized, smooth surfaces. 99.9% of ... the processing of the PMMA. Artecoll contains ...
... Dysport is a simple, effective, non-surgical treatment ... the forehead, thereby reducing and smoothing away ... over a decade of clinical experience. Dysport ... the early 1990s to successfully treat a ...
Medicine Products: